1 / 1

Comparative Analysis of PC3pip Tumor Uptake of PSMA-1-IR800 and PSMA-1-Cy5.5 via FMT

This figure illustrates the quantification of tumor uptake for PSMA-1-IR800 and PSMA-1-Cy5.5 in PC3pip cells, as determined by fluorescence molecular tomography (FMT). The PSMA-1-IR800 compound peaked at 4 hours post-injection, showing a gradual decline thereafter. In contrast, PSMA-1-Cy5.5 reached its maximum uptake at 24 hours post-injection and maintained a stable level. This comparison highlights the distinct kinetic profiles of these two imaging agents in tumor-targeted applications.

julie
Télécharger la présentation

Comparative Analysis of PC3pip Tumor Uptake of PSMA-1-IR800 and PSMA-1-Cy5.5 via FMT

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Figure S4 Figure S4: Comparison of the quantification of PC3pip tumor uptake of PSMA-1-IR800 and PSMA-1-Cy5.5 as determined by FMT. The amount of PSMA-1-IR800 in PC3pip reached a maximum at 4 hours post injection, then dropped gradually. The amount of PSMA-1-Cy5.5 reached its peak at 24 hours post injection, then remained constant.

More Related